NEW YORK--(BUSINESS WIRE)--Guard Dog Brand Development (www.GuardDogBD.com) is proud to be an event exhibitor and sponsor of CBI’s 6th Annual Forum on Oncology Market Access and Payer Strategies on Wednesday, January 30, 2013 at the DoubleTree by Hilton, Philadelphia, PA.
“Science identity helps to convey an oncology product’s true value right from the start of the commercialization process and contributes to a product’s ultimate success”
“Given Guard Dog’s expertise in science identity development as an essential element in oncology commercialization strategies, we believe it is critically important to sponsor this event, which will convene a variety of thought leaders who will explore the key elements of the commercialization side of oncology,” said Camille DeSantis, co-founder and chief of brand strategy at Guard Dog Brand Development, a boutique company with a particular expertise in early science identity development for oncology products.
“Science identity helps to convey an oncology product’s true value right from the start of the commercialization process and contributes to a product’s ultimate success,” said Maria Casini, co-founder and chief of strategic brand design of Guard Dog.
About Guard Dog Brand Development® (GDBD):
GDBD is a WBENC-certified, women-owned, independent identity development company specializing Fiercely Protective® corporate, franchise, portfolio, science, and product identities. Please visit www.GuardDogBD.com for more information.
About CBI’s 6th Annual Forum on Oncology Market Access and Payer Strategies
This annual forum allows participants to learn about assessing the current industry landscape, implementing proven market access strategies, and improving payer relationships to achieve commercial success in oncology. For more information, go to www.cbinet.com/Oncology or call 1-800-818-8601.